A Pilot Study Examining the Efficacy of a Support Algorithm for Commencing Patients with Type 2 Diabetes on a Basal / Prandial Insulin Regimen in the Primary Care Setting With Professional Continuous Glucose Monitoring as an Adjunct.

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 08 Jun 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Insulin glargine (Primary) ; Insulin glulisine (Primary)
Indications Type 2 diabetes mellitus
Focus Therapeutic Use
Acronyms INITIATION
Sponsors Sanofi

Most Recent Events

31 May 2012 Status changed from not yet recruiting to recruiting as reported by Australian New Zealand Clinical Trials Registry record.
28 May 2012 Additional lead trial centre identified as reported by Australian New Zealand Clinical Trials Registry.
17 Aug 2011 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight